Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.

Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.

Microarray patches (MAPs) have the potential to be a safer, more acceptable, easier to use and more cost-effective method for administration of vaccines when compared to the needle and syringe. Since MAPs deliver vaccine to the dermis and epidermis, a degree of local immune response at the site of a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexandra C I Depelsenaire, Katey Witham, Margaret Veitch, James W Wells, Christopher D Anderson, Jason D Lickliter, Steve Rockman, Jesse Bodle, Peter Treasure, Julian Hickling, Germain J P Fernando, Angus H Forster
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/61371d0df36f45c29c01e75d282c49e0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares